Multiple sclerosis is a chronic, demyelinating disease of the CNS. Cognitive impairment is a
sometimes neglected, yet common, sign and symptom with a profound effect on instrumental …

Purpose: To promote understanding of cognitive impairment in multiple sclerosis (MS),
recommend optimal screening, monitoring, and treatment strategies, and address barriers to …

Neuropsychiatric abnormalities may be broadly divided in two categories: disorders of
mood, affect, and behavior and abnormalities affecting cognition. Among these conditions …

Objective To investigate the effects of siponimod on cognitive processing speed in patients
with secondary progressive (SP) multiple sclerosis (MS), by means of a predefined …

Background. Cognitive impairments are common in people with multiple sclerosis (MS).
Systematic reviews reported promising evidence for various cognitive interventions in this …

Abstract Purpose of Review Multiple sclerosis (MS) is a demyelinating disease of the central
nervous system that mainly affects young adults and that is one of the leading causes of …

Objective Multiple sclerosis (MS) is associated with cognitive impairment (CI) such as
slowed information processing speed (IPS). Currently, no immunocellular or molecular …

Many patients with multiple sclerosis (MS) experience information processing speed (IPS)
deficits, and the Symbol Digit Modalities Test (SDMT) has been recommended as a valid …

The imbalance in the concentration of metallic nanoparticles has been demonstrated to play
an important role in multiple sclerosis (MS), which may impact cognition. Biomarkers are …

Introduction: Cognitive impairment in multiple sclerosis (MS) is increasingly being
investigated with resting-state functional MRI (rs-fMRI) functional connectivity (FC). However …